LONDON — A Novartis executive on Thursday said “it’s too early to say” whether the company would still submit an experimental myelofibrosis drug for regulatory
LONDON — Roche on Wednesday reported positive early data from another of the obesity drug candidates that it picked up through an acquisition late last
Facing increasing doubts that the U.S. can control the outbreak of avian influenza among dairy cattle, federal officials reiterated on Tuesday that they believe the
When, in April, the federal government began requiring some cows to be tested for a strain of avian flu before their herds could be moved
LONDON — Seth Berkley, a longtime and widely respected global health leader, said Thursday that it has been “shocking to watch the ineptitude” of the
LONDON — A major shakeup in how the benefits of medicines are assessed in Europe is looming, and developers of treatments like gene therapies are
Greetings from London, with STAT reporter Andrew Joseph here filling in for Ed. We’re dealing with some decidedly June Gloom today, though we suppose that
LONDON — The resurrection of a GSK blood cancer drug — which the company withdrew from the U.S. market not even two years ago after
LONDON — Merck said Wednesday it is buying ophthalmology-focused startup EyeBio in a deal worth up to $3 billion, as the pharma company looks to
An experimental drug from Insmed Incorporated successfully reduced lung problems among patients with an airway disease in a closely watched Phase 3 trial, sending the